Clinical Trial Update: Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting safety and immunogenicity of a single dose of Novartis' Meningococcal ACWY-CRM vaccine and GlaxoSmithKline's Meningococcal ACWY-T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Meningococcal ACWY-CRM vaccine
• Meningococcal ACWY-TT vaccine

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-11-04